Harbor Capital Advisors Inc. Trims Position in Encompass Health Co. (NYSE:EHC)

Harbor Capital Advisors Inc. decreased its holdings in shares of Encompass Health Co. (NYSE:EHC) by 0.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 72,627 shares of the company’s stock after selling 645 shares during the quarter. Harbor Capital Advisors Inc. owned 0.07% of Encompass Health worth $6,707,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. UMB Bank n.a. lifted its position in Encompass Health by 387.7% in the third quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after purchasing an additional 252 shares during the last quarter. V Square Quantitative Management LLC raised its holdings in shares of Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after acquiring an additional 140 shares in the last quarter. Avior Wealth Management LLC bought a new position in shares of Encompass Health during the third quarter valued at approximately $40,000. Benjamin F. Edwards & Company Inc. raised its holdings in shares of Encompass Health by 58.9% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock valued at $46,000 after acquiring an additional 198 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new stake in Encompass Health in the second quarter worth $58,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the company. Truist Financial reissued a “buy” rating and issued a $116.00 target price (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. UBS Group increased their price objective on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, September 25th. Barclays increased their price objective on Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. KeyCorp increased their target price on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Finally, Royal Bank of Canada increased their target price on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Nine analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $107.11.

Encompass Health Price Performance

NYSE EHC traded down $1.08 during trading on Friday, hitting $91.76. 126,768 shares of the stock traded hands, compared to its average volume of 591,432. The company has a market capitalization of $9.24 billion, a P/E ratio of 22.16, a price-to-earnings-growth ratio of 1.30 and a beta of 0.89. The firm has a 50-day simple moving average of $98.39 and a 200-day simple moving average of $93.61. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health Co. has a 12-month low of $67.94 and a 12-month high of $104.55.

Encompass Health (NYSE:EHC) last announced its earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The company’s quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.86 EPS. As a group, analysts predict that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.74%. The ex-dividend date is Thursday, January 2nd. Encompass Health’s dividend payout ratio is currently 16.43%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.